Nanotechnology Now

Heifer International

Wikipedia Affiliate Button


Home > Press > RUSNANO delegation to visit Israel on March 18-21

On March 18 a delegation of the Russian Corporation of Nanotechnologies (RUSNANO) headed by CEO Anatoly Chubais has arrived at Israel.

RUSNANO delegation to visit Israel on March 18-21

Moscow, Russia | Posted on March 23rd, 2009

Israel is one of the Corporation's main partners abroad. The country is rapidly gaining ground versus the chief players in the nanotechnology market, such as the USA, Germany, South Korea and Taiwan. According to key indicators, such as the number of nano-technological publications and patents, the number of universities, Israel can be considered one of the most advanced countries.

In the course of the trip the RUSNANO delegation will have a number of meetings with the leaders of Israeli venture funds and top companies in the field of nanotechnologies, including ELRON, SELA, MCL, and Telco Systems. Some of them have already applied for partnership with RUSNANO and their offers are being appraised by Corporation.

Anatoly Chubais will hold meetings with Israeli President Shimon Peres and elected premier-minister Benjamin Netanyahu. Corporate management will hold a working meeting with the Chief scientist of the Ministry for Industry, Trade and Labor of Israel Elie Opper, who is responsible for the development of industrial research and developments in the country.

The program also includes a reception at the residence of Russian Ambassador to Israel Peter Stegny, which will see the participation of the chief representatives of Israel's political and business communities.


About Russian Corporation of Nanotechnologies
The Russian Corporation of Nanotechnologies (RUSNANO) was established under the Federal Law ¹ 139-FZ in September 2007. The mission of RUSNANO is to advance Russia into the pool of the world’s leaders in the field of nanotechnologies. The priority of RUSNANO is commercialization of nanotechnology projects with high business potential and/or social benefit. The Corporation has 130 billion rubles (about $5 billion) under management, provided solely by the Russian Government.

Anna Fradkova
Press-secretary of the international press office
P.: +7 495 5424444 add.1424
M.: +7 985 7299860

Copyright © Russian Corporation of Nanotechnologies

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Untangling DNA with a droplet of water, a pipet and a polymer: With the 'rolling droplet technique,' a DNA-injected water droplet rolls like a ball over a platelet, sticking the DNA to the plate surface February 27th, 2015

Rice's Stephan Link honored for nanoscience research: The Welch Foundation honors ‘rising star’ with $100,000 Hackerman Award February 26th, 2015

Indefinite Life Extension Activists Organize Online Demonstration February 26th, 2015

Renishaw and Bruker team up for a workshop on TERS and co-localised AFM Raman February 26th, 2015


Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015

Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015

Harris & Harris Group Portfolio Company D-Wave Systems Raises an Additional $29 Million (CAD), Closing 2014 Financing at $62 Million (CAD) February 2nd, 2015

Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015


Untangling DNA with a droplet of water, a pipet and a polymer: With the 'rolling droplet technique,' a DNA-injected water droplet rolls like a ball over a platelet, sticking the DNA to the plate surface February 27th, 2015

Real-time observation of bond formation by using femtosecond X-ray liquidography February 26th, 2015

Bruker-Sponsored Sixth AFM BioMed Conference Highlights Increasing Impact of AFM in Biological Applications February 26th, 2015

Graphene shows potential as novel anti-cancer therapeutic strategy: University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells February 26th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE